Head & Neck最新文献

筛选

英文中文

Functional analysis of swallowing outcomes after supracricoid partial laryngectomy. 喉瓣上部分切除术后吞咽功能分析。

IF 2.9

Head & Neck Pub Date : 2008-05-01 DOI: 10.1002/hed.20738

Jan S Lewin, Katherine A Hutcheson, Denise A Barringer, Annette H May, Dianna B Roberts, F Christopher Holsinger, Eduardo M Diaz

{"title":"Functional analysis of swallowing outcomes after supracricoid partial laryngectomy.","authors":"Jan S Lewin, Katherine A Hutcheson, Denise A Barringer, Annette H May, Dianna B Roberts, F Christopher Holsinger, Eduardo M Diaz","doi":"10.1002/hed.20738","DOIUrl":"https://doi.org/10.1002/hed.20738","url":null,"abstract":"Background: In this study, we analyzed swallowing recovery after supracricoid partial laryngectomy (SCPL).Methods: We retrospectively reviewed 27 patients treated with SCPL (September 1997 to March 2005). We evaluated recovery course, nutritional outcomes, and swallowing using objective analysis. Modified barium swallow (MBS) study results identified swallowing physiology and therapeutic effectiveness.Results: Average length of hospitalization was 7.7+/-9.2 days; time to decannulation was 5.3+/-8.2 weeks. The most common complications included pneumonia and subcutaneous emphysema (26%). Twenty-two patients had MBS studies, in which initially, all patients aspirated due to neoglottic incompetency, and impaired base of tongue and laryngeal movements. Although aspiration rates did not change significantly over time, use of appropriately selected swallowing strategies effectively protected the airway (p= .0365). Ultimately, 81% of patients returned to complete oral intake with median tube removal at 9.4 weeks.Conclusion: SCPL produces severe dysphagia initially. Our findings suggest that objective swallowing assessment is important for return to oral nutrition after SCPL.","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"559-66"},"PeriodicalIF":2.9,"publicationDate":"2008-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.20738","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27133657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 82

Management of sinonasal undifferentiated carcinoma. 鼻窦未分化癌的治疗。

IF 2.9

Head & Neck Pub Date : 2008-05-01 DOI: 10.1002/hed.20748

Emily D Tanzler, Christopher G Morris, Christine A Orlando, John W Werning, William M Mendenhall

{"title":"Management of sinonasal undifferentiated carcinoma.","authors":"Emily D Tanzler, Christopher G Morris, Christine A Orlando, John W Werning, William M Mendenhall","doi":"10.1002/hed.20748","DOIUrl":"https://doi.org/10.1002/hed.20748","url":null,"abstract":"Background: Our aim was to report the outcomes of treatment for sinonasal undifferentiated carcinoma (SNUC).Methods: Between September 1992 and October 2005, 15 patients were treated with curative intent with surgery (n=1), surgery and adjuvant radiotherapy (n=9), and definitive radiotherapy (RT) (n=5). Follow-up ranged from 11 to 151 months (median, 30); follow-up on living patients ranged from 12 to 151 months (median, 22). No patient was lost to follow-up.Results: Seven patients (47%) developed a recurrence from 3 to 50 months (median, 9) after treatment. The 3-year outcomes were: local control, 78%; locoregional control, 65%; distant metastasis-free survival, 82%; cause-specific survival, 77%, and survival, 67%. The local control rates versus treatment modality were: surgery, 0/1 (0%); surgery and postoperative RT, 7/7 (100%); preoperative RT and surgery, 2/2 (100%); and definitive RT, 2/5 (40%). One patient (7%) treated with surgery and postoperative RT sustained a fatal complication.Conclusions: Combined surgery and adjuvant RT likely offer the best chance of cure compared with either modality alone. The impact of adjuvant chemotherapy is unclear.","PeriodicalId":501638,"journal":{"name":"Head & Neck","volume":" ","pages":"595-9"},"PeriodicalIF":2.9,"publicationDate":"2008-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/hed.20748","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27358374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 89

首页上一页